Skip to main content
Top
Published in: Indian Journal of Gastroenterology 4/2014

01-07-2014 | Original Article

Central venous pressure catheter for large-volume paracentesis in refractory ascites

Authors: Shahram Agah, Sahar Tavakoli, Hajar Nikbakht, Mehrdokht Najafi, Abdolreza Al-agha

Published in: Indian Journal of Gastroenterology | Issue 4/2014

Login to get access

Abstract

Background and Aims

About 10 % of cirrhotic patients are unresponsive to sodium restriction and diuretics and develop refractory ascites. Such patients usually require recurrent large-volume paracentesis and lots of hospital admissions. Hereby, we introduce a method applying a central vein (CV) catheter for large-volume paracentesis in patients with refractory ascites in up to 4 days associated with sodium restriction and high dose of diuretics.

Methods

Non-tunneled triple lumen CV catheter was used to drain the ascites fluid of 30 cirrhotic patients. After precise percussion, the point of highest fluid accumulation was marked for puncture. Then, the skin and subcutaneous tissue were anesthetized. CV catheter set guide wire was entered into the peritoneal cavity and the dilator of the CV catheter set was passed through the guide wire and extracted after some rotations around its insertion site on the skin. The catheter was passed over the guide wire and the guide wire was extracted gradually from one of the lumens and fixed to the skin.

Results

Nineteen males and 11 females with mean (±SD) age of 59.4 ± 11.7 years old underwent the procedure. A minimum of 9 and maximum of 29 L (12 ± 6.6 L) ascites fluid drained during a minimum of 2 and maximum of 5 days of hospital stay. All catheters were patent during the drainage. None of the patients developed hemodynamic instability. Number of re-hospitalizations for paracentesis was 1.9 times during the following year. No complication occurred.

Conclusions

This technique is a simple noninvasive method that can be performed in the endoscopy unit or even at the patient’s bedside and may reduce the need for repeated admissions.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kim WR, Brown JR, Terrault NA, et al. Burden of liver disease in the United States: summary of the workshop. Hepatology. 2002;36:227–42.PubMedCrossRef Kim WR, Brown JR, Terrault NA, et al. Burden of liver disease in the United States: summary of the workshop. Hepatology. 2002;36:227–42.PubMedCrossRef
2.
go back to reference Gines P, Quintero E, Arroyo V, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology. 1987;7:12–8.CrossRef Gines P, Quintero E, Arroyo V, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology. 1987;7:12–8.CrossRef
3.
go back to reference Powell WJ, Klatskin G. Duration of survival in patients with Laennec’s cirrhosis of the liver. Am J Med. 1968;44:406–20.PubMedCrossRef Powell WJ, Klatskin G. Duration of survival in patients with Laennec’s cirrhosis of the liver. Am J Med. 1968;44:406–20.PubMedCrossRef
4.
go back to reference D’Amico G, Morabito A, Pagliaro L, et al. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci. 1986;31:468–75.PubMedCrossRef D’Amico G, Morabito A, Pagliaro L, et al. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci. 1986;31:468–75.PubMedCrossRef
5.
go back to reference Llach J, Gines P, Arroyo V, et al. Prognostic value of arterial pressure, endogenous vasoconstrictive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology. 1988;94:482–7.PubMed Llach J, Gines P, Arroyo V, et al. Prognostic value of arterial pressure, endogenous vasoconstrictive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology. 1988;94:482–7.PubMed
10.
go back to reference Runyon BA. Ascites and spontaneous bacterial peritonitis. In: Feldman M, Friedman LS, Brandt LJ, et al. eds. Sleisenger and Fordtran’s Gastrointestinal and Liver Disease. Philadelphia: Saunders; 2010. Pp. 1517–41 (2) 9. Runyon BA. Ascites and spontaneous bacterial peritonitis. In: Feldman M, Friedman LS, Brandt LJ, et al. eds. Sleisenger and Fordtran’s Gastrointestinal and Liver Disease. Philadelphia: Saunders; 2010. Pp. 1517–41 (2) 9.
12.
go back to reference Jansen M, Truong S, Reisener KP, et al. Results of sonographically guided percutaneous catheter drainage of intra-abdominal abscesses in surgery. Chirurg. 1999;70:1168–71.PubMedCrossRef Jansen M, Truong S, Reisener KP, et al. Results of sonographically guided percutaneous catheter drainage of intra-abdominal abscesses in surgery. Chirurg. 1999;70:1168–71.PubMedCrossRef
13.
go back to reference Rosenberg SM. Palliation of malignant ascites. Gastroenterol Clin N Am. 2006;35:189–99.CrossRef Rosenberg SM. Palliation of malignant ascites. Gastroenterol Clin N Am. 2006;35:189–99.CrossRef
14.
go back to reference Reisfield GM, Wilson GR. Management of intractable cirrhotic ascites with an indwelling drainage catheter. J Palliat Med. 2003;6:787–91.PubMedCrossRef Reisfield GM, Wilson GR. Management of intractable cirrhotic ascites with an indwelling drainage catheter. J Palliat Med. 2003;6:787–91.PubMedCrossRef
15.
go back to reference Guevara M, Cardenas A, Uriz J, et al. Prognosis of patients with cirrhosis and ascites. In: Gines P, Arroyo V, Rodes J, Schrier RW, et al. eds. Ascites and Renal Dysfunction in Liver Disease: Pathogenesis, Diagnosis, and Treatment. Malden, Mass: Blackwell Science; 2005. Pp. 260–71.CrossRef Guevara M, Cardenas A, Uriz J, et al. Prognosis of patients with cirrhosis and ascites. In: Gines P, Arroyo V, Rodes J, Schrier RW, et al. eds. Ascites and Renal Dysfunction in Liver Disease: Pathogenesis, Diagnosis, and Treatment. Malden, Mass: Blackwell Science; 2005. Pp. 260–71.CrossRef
16.
go back to reference Runyon BA. AASLD practice guidelines committee. Management of adult patients with ascites due to cirrhosis: an update. Hepatology. 2009;49:2087–107.PubMedCrossRef Runyon BA. AASLD practice guidelines committee. Management of adult patients with ascites due to cirrhosis: an update. Hepatology. 2009;49:2087–107.PubMedCrossRef
17.
go back to reference Sanyal AJ, Genning C, Reddy RK, et al. The North American study for the treatment of refractory ascites. Gastroenterology. 2003;124:634–41.PubMedCrossRef Sanyal AJ, Genning C, Reddy RK, et al. The North American study for the treatment of refractory ascites. Gastroenterology. 2003;124:634–41.PubMedCrossRef
18.
go back to reference Gines P, Uriz J, Calahorra B, et al. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology. 2002;123:1839–47.PubMedCrossRef Gines P, Uriz J, Calahorra B, et al. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology. 2002;123:1839–47.PubMedCrossRef
19.
go back to reference Hussain FF, Meer ZF, Lopez AJ. Peritoneovenous shunt insertion for intractable ascites: a district general hospital experience. Cardiovasc Intervent Radiol. 2004;27:325–8.PubMedCrossRef Hussain FF, Meer ZF, Lopez AJ. Peritoneovenous shunt insertion for intractable ascites: a district general hospital experience. Cardiovasc Intervent Radiol. 2004;27:325–8.PubMedCrossRef
20.
go back to reference Park JS, Won JY, Park SI, et al. Percutaneous peritoneovenous shunt creation for the treatment of benign and malignant refractory ascites. J Vasc Intervent Radiol. 2001;12:1445–8.CrossRef Park JS, Won JY, Park SI, et al. Percutaneous peritoneovenous shunt creation for the treatment of benign and malignant refractory ascites. J Vasc Intervent Radiol. 2001;12:1445–8.CrossRef
21.
go back to reference Rosemurgy AS, Zervos EE, Clark WC, et al. TIPS versus peritoneovenous shunt in the treatment of medically intractable ascites: a prospective randomized trial. Ann Surg. 2004;239:883–91.PubMedCentralPubMedCrossRef Rosemurgy AS, Zervos EE, Clark WC, et al. TIPS versus peritoneovenous shunt in the treatment of medically intractable ascites: a prospective randomized trial. Ann Surg. 2004;239:883–91.PubMedCentralPubMedCrossRef
22.
go back to reference Rozenblit GN, Del Guercio LRM, Rundback JH, et al. Peritoneal-urinary drainage for treatment of refractory ascites: a pilot study. J Vasc Intervent Radiol. 1998;9:998–1005.CrossRef Rozenblit GN, Del Guercio LRM, Rundback JH, et al. Peritoneal-urinary drainage for treatment of refractory ascites: a pilot study. J Vasc Intervent Radiol. 1998;9:998–1005.CrossRef
23.
go back to reference Lorentzen T, Sengelov L, Nolsoe CP, et al. Ultrasonographically guided insertion of a peritoneo-gastric shunt in patients with malignant ascites. Acta Radiol. 1995;36:481–4.PubMedCrossRef Lorentzen T, Sengelov L, Nolsoe CP, et al. Ultrasonographically guided insertion of a peritoneo-gastric shunt in patients with malignant ascites. Acta Radiol. 1995;36:481–4.PubMedCrossRef
24.
go back to reference O'Neill MJ, Weissleder R, Gervais DA, Hahn PF, Mueller PR. Tunneled peritoneal catheter placement under sonographic and fluoroscopic guidance in the palliative treatment of malignant ascites. AJR Am J Roentgenol. 2001;177:615–8. O'Neill MJ, Weissleder R, Gervais DA, Hahn PF, Mueller PR. Tunneled peritoneal catheter placement under sonographic and fluoroscopic guidance in the palliative treatment of malignant ascites. AJR Am J Roentgenol. 2001;177:615–8.
25.
go back to reference Richard HM, Coldwell DM, Boyd-Kranis RL, et al. Pleurx tunneled catheter in the management of malignant ascites. J Vasc Intervent Radiol. 2001;12:373–5.CrossRef Richard HM, Coldwell DM, Boyd-Kranis RL, et al. Pleurx tunneled catheter in the management of malignant ascites. J Vasc Intervent Radiol. 2001;12:373–5.CrossRef
26.
go back to reference Sartori S, Nielsen I, Trevisani L, et al. Sonographically guided peritoneal catheter placement in the palliation of malignant ascites in end-stage malignancies. AJR Am J Roentgenol. 2002;179:1618–20. Sartori S, Nielsen I, Trevisani L, et al. Sonographically guided peritoneal catheter placement in the palliation of malignant ascites in end-stage malignancies. AJR Am J Roentgenol. 2002;179:1618–20.
27.
go back to reference Barnett TD, Rubins J. Placemet of a permanent tunneled peritoneal drainage catheter for palliation of malignant ascites: a simplified percutaneous approach. J Vasc Intervent Radiol. 2002;13:379–83.CrossRef Barnett TD, Rubins J. Placemet of a permanent tunneled peritoneal drainage catheter for palliation of malignant ascites: a simplified percutaneous approach. J Vasc Intervent Radiol. 2002;13:379–83.CrossRef
28.
go back to reference Sabatelli FW, Glassman ML, Kerns SR, et al. Permanent indwelling peritoneal access device for the management of malignant ascites. Cardiovasc Intervent Radiol. 1994;17:292–4.PubMedCrossRef Sabatelli FW, Glassman ML, Kerns SR, et al. Permanent indwelling peritoneal access device for the management of malignant ascites. Cardiovasc Intervent Radiol. 1994;17:292–4.PubMedCrossRef
29.
go back to reference Rosenblum DI, Geisinger MA, Newman JS, et al. Use of subcutaneous venous access ports to treat refractory ascites. J Vasc Intervent Radiol. 2001;12:1343–6.CrossRef Rosenblum DI, Geisinger MA, Newman JS, et al. Use of subcutaneous venous access ports to treat refractory ascites. J Vasc Intervent Radiol. 2001;12:1343–6.CrossRef
Metadata
Title
Central venous pressure catheter for large-volume paracentesis in refractory ascites
Authors
Shahram Agah
Sahar Tavakoli
Hajar Nikbakht
Mehrdokht Najafi
Abdolreza Al-agha
Publication date
01-07-2014
Publisher
Springer India
Published in
Indian Journal of Gastroenterology / Issue 4/2014
Print ISSN: 0254-8860
Electronic ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-014-0448-0

Other articles of this Issue 4/2014

Indian Journal of Gastroenterology 4/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.